A randomised trial comparing the safety and efficacy of the Zoladex 10.8-mg depot, administered every 12 weeks, to that of the Zoladex 3.6-mg depot, administered every 4 weeks, in patients with advanced prostate cancer. The Dutch South East Cooperat (Q72221592)
Jump to navigation
Jump to search
scientific article published on 01 January 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised trial comparing the safety and efficacy of the Zoladex 10.8-mg depot, administered every 12 weeks, to that of the Zoladex 3.6-mg depot, administered every 4 weeks, in patients with advanced prostate cancer. The Dutch South East Cooperat |
scientific article published on 01 January 1995 |
Statements
A randomised trial comparing the safety and efficacy of the Zoladex 10.8-mg depot, administered every 12 weeks, to that of the Zoladex 3.6-mg depot, administered every 4 weeks, in patients with advanced prostate cancer. The Dutch South East Cooperative Urological Group (English)
G A Dijkman
F M Debruyne
P Fernandez del Moral
J W Plasman
J W Hoefakker
J G Idema